Fertility preserving treatments for endometrial cancer: The unanswered questions

Gynecologic Oncology

Volumn 129, Issue 1, 2013, Pages 1-2

  Gotlieb, Walter H ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE;

CANCER RECURRENCE; COLON CANCER; CONSERVATIVE TREATMENT; DECIDUALIZATION; DISEASE SPECIFIC SURVIVAL; EDITORIAL; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; LIVE BIRTH; MULTICENTER STUDY (TOPIC); OVARIECTOMY; PREGNANCY; PRIORITY JOURNAL; QUALITY OF LIFE; REPRODUCTIVE PROCEDURE; SUSCEPTIBILITY WEIGHTED IMAGING;

ADENOCARCINOMA; ENDOMETRIAL NEOPLASMS; FEMALE; FERTILITY PRESERVATION; HUMANS; NEOPLASM RECURRENCE, LOCAL; PROGESTINS;

EID: 84875464813     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.02.031     Document Type: Editorial

References (13)

1. H. Lajer, S. Elnegaard, R.D. Christensen, G. Ortoft, D.E. Schledermann, and O. Mogensen Survival after stage lA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey Acta Obstet Gynecol Scand 91 2012 977 982
2. Mathews TJ, Hamilton BE. Delayed childbearing: more women are having their first child later in life. NCHS data brief, no 21. Hyattsville, MD: National Center for Health Statistics.
3. R.M. Kelley, and W.H. Baker Progestational agents in the treatment of carcinoma of the endometrium NEJM 264 1961 216
4. I.D. Gallos, J. Yap, and M. Rajkhowa Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis Am J Obstet Gynecol 207 266 2012 e1 e12
5. J.Y. Park, D.Y. Kim, J.H. Kim, Y.M. Kim, K.R. KIM, and Y.T. Kim Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002) Eur J Cancer 49 4 2013 868 874
6. W.H. Gotlieb, M.E. Beiner, B. Shalmon, Y. Korach, Y. Segal, and N. Zmira Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer Obstet Gynecol 102 2003 718 725
7. J.Y. Park, S.H. Lee, S.J. Seong, D.Y. Kim, T.J. Kim, J.W. Kim, J.H. Kim, Y.M. Kim, Y.T. Kim, D.S. Bae, and J.H. Nam Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin Gynecol Oncol 129 1 2013 4 8
8. M.M. Leitao Jr., S. Kehoe, R.R. Barakat, K. Alektiar, L.P. Gattoc, and C. Rabbitt Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma Gynecol Oncol 113 1 2009 105 108
9. L.M. Wu, J.R. Xu, H.Y. Gu, J. Hua, E.M. Haacke, and J. Hu Predictive value of T2-weighted imaging and contrast-enhanced MR imaging in assessing myometrial invasion in endometrial cancer: a pooled analysis of prospective studies Eur Radiol 23 2 2013 435 449
10. C. Walsh, C. Holschneider, and Y. Hoang Coexisting ovarian malignancy in young women with endometrial cancer Obstet Gynecol 106 2005 693 699
11. K.R. Penner, O.C. Dorigo, N. Ostrzega, B.L. Balzer, J. Rao, and C.S. Walsh Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy Gynecol Oncol 124 2012 542 548
12. J.D. Wright, A.M. Buck, M. Shah, W.M. Burke, P.B. Schiff, and T.J. Herzog Safety of ovarian preservation in premenopausal women with endometrial cancer J Clin Oncol 27 2009 1214 1219
13. J.M. Lancaster, C.B. Powell, and N.D. Kauff Society of Gynecologic Oncologists 309 Education Committee statement on risk assessment for inherited gynecologic cancer 310 predispositions Gynecol Oncol 107 2007 159 162